DURHAM, N.C., Nov. 9, 2022 /PRNewswire/ -- Baebies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) ...
Newborn screening for an inherited genetic condition that affects people of several ethnicities could reduce the risk of long-term disability for many on Long Island, doctors and advocates say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results